PMM2-CDG Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

3Recruiting trials

🩺

16Specialists

Regulatory Watchboard

3 events

Jul 2025A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

Glycomine, Inc. — PHASE2, PHASE3

TrialACTIVE NOT RECRUITING

Sep 2024Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients

Glycomine, Inc. — PHASE2

TrialENROLLING BY INVITATION

Jan 2018Natural History Study Protocol in PMM2-CDG (CDG-Ia)

Glycomine, Inc.

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for PMM2-CDG.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials

1Phase 2

1Unknown

1PHASE2, PHASE3

3Total recruiting

Search clinical trials for PMM2-CDG →

Recent News & Research

No recent news articles indexed yet for PMM2-CDG.
Search PubMed for PMM2-CDG →

Browse all PMM2-CDG news →

Specialist Network

Top 6 by expertise

Eva Morava-Kozicz, MD, PhD, M.D

Icahn School of Medicine at Mount Sinai

📍 ROCHESTER, MN

Score 117 trials

Mercedes Serrano

Hospital Sant Joan de Déu

Score 04 pubs

Peter Witters

University Hospitals Leuven

Score 03 pubs

Anna N Ligezka

linical Genomics

Score 03 pubs

Mirian C H Janssen

Radboud University Medical Centre

Score 03 pubs

Dulce Quelhas

Centro Hospitalar Universitário do Porto

Score 04 pubs

View all PMM2-CDG specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰